Marco L. Lolli

机构：University of Turin · ORCID：0000-0002-3030-3163

发表论文 133 篇 · 总被引 2176 次 · h-index 27

代表论文

• AI is a viable alternative to high throughput screening: a 318-target study (2024 · Scientific Reports · 被引 128)
• DHODH inhibitors: What will it take to get them into the clinic as antivirals? (2025 · Antiviral Research · 被引 15)
• A comprehensive review of synthetic strategies and SAR studies for the discovery of PfDHODH inhibitors as antimalarial agents. Part 1: triazolopyrimidine, isoxazolopyrimidine and pyrrole-based (DSM) compounds (2024 · Bioorganic Chemistry · 被引 15)
• Off-Target Inhibition of Human Dihydroorotate Dehydrogenase ( h DHODH) Highlights Challenges in the Development of Fat Mass and Obesity-Associated Protein (FTO) Inhibitors (2024 · ACS Pharmacology & Translational Science · 被引 12)
• Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer (2024 · European Journal of Medicinal Chemistry · 被引 12)
• Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication (2023 · Antiviral Research · 被引 12)